AHA 2022 Conference Coverage
M

AHA 2022: Genomic Therapies for Hereditary Transthyretin (TTR) Amyloidosis

By AHA 2022 Conference Coverage FEATURING Marianna Fontana
By AHA 2022 Conference Coverage FEATURING Marianna Fontana
0 views
November 29, 2022
Comments 0
Login to view comments. Click here to Login

Recommended

AUTOPLAY
12:18
CCM® Therapy

HRS 2024: Cardiac Contractility Modulation - Don’t Wait!

Feat. R. Kahwash
35:16
Scripps Health

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Feat. M. Kittleson
12:30
Houston Methodist Hospital

Amyloidosis Types and Pathophysiology

Feat. B. Trachtenberg
13:58
CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT (Dr. Heywood)

Feat. J. Thomas Heywood
10:09
Inova Heart and Vascular Institute - Advanced Heart Failure Symposium

Cardiac Amyloidosis: An Overlooked but Treatable Cause of HFpEF

16:45
SOHO 2022 Tenth Annual Meeting

SOHO 2022: Amyloidosis - Update and How To Use Novel Agents

Feat. S. Lentzsch
40:17
American College of Cardiology

Heart Failure with Preserved Ejection Fraction: Current Perspectives…

Feat. S. Shah
17:29
UCLA Health

Cardiac Amyloidosis: A New Era of Diagnostics and Therapeutics

Feat. D. Vucicevic
06:16
CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT

Feat. D. Yaranov
11:28
Yale Cancer Center

Overview of Cardiac Amyloidosis

Feat. E. Miller
06:23
CVRx | Barostim

ESC 2023: Baroreflex Activation Therapy for HFrEF Patients: Long-Ter…

Feat. W. Abraham, F. Arribas, M. Zile
11:49
CVRx | Barostim

ESC 2023: Unmet needs and opportunities with device therapies of HFr…

Feat. W. Abraham
12:21
CVRx | Barostim

Baroreflex Activation Therapy Overview of Clinical Data

Feat. L. Tsao
28:03
Houston Methodist DeBakey Heart and Vascular Center

How to Detect and Treat Heart Failure with Preserved Ejection Fracti…

15:23
Canadian Collaborative Research Network

New Diagnostic and Treatment Strategies in Cardiac Amyloidosis

Feat. M. Davis
16:11
Jeffrey Weitz

Extended Anticoagulation for VTE

11:50
American Heart & Vascular Institute

New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. …

Feat. M. Kittleson
19:30
American Heart & Vascular Institute

ISCHEMIA Trial: Are We Overusing Cardiac Stents? Is Revascularizatio…

Feat. B. Reddy
21:36
NYU Langone

Emerging Therapies in Cardiac Amyloidosis

Feat. M. Hanna
14:18
CCM® Therapy

The CCM Solution: How Does it Work and What Does it Do?

Feat. N. Varma